Loading clinical trials...
Loading clinical trials...
Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce
This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may allow for more comprehensive actions to be taken to protect the mental health of employees.
PRIMARY OBJECTIVE: I. To assess psychosocial and stress-related outcomes in employees at MD Anderson Cancer Center during and post the COVID-19 pandemic. SECONDARY OBJECTIVE: I. To identify demographic and occupational factors associated with COVID-19 related psychosocial and stress outcomes. OUTLINE: Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
May 18, 2020
Primary Completion Date
April 30, 2026
Completion Date
April 30, 2026
Last Updated
January 28, 2026
20,000
ESTIMATED participants
Questionnaire Administration
OTHER
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
NCT06381739
NCT04582903
NCT04474301
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions